Global Gastrointestinal Stents Market Size By Type (Self-expanding Metal Stents, Plastic Stents), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Gastrointestinal Stents Market was valued at USD 513.2 million in 2023 and is projected to reach USD 872.9 million by 2031, growing at a CAGR of 6.8% during the forecast period (2023–2031). This growth is primarily driven by the rising incidence of gastrointestinal cancers and strictures, increasing preference for minimally invasive procedures, and technological advancements in stent design. Gastrointestinal stents play a crucial role in relieving obstructions in the esophagus, colon, duodenum, and biliary tract, improving patient outcomes and quality of life.

Drivers:

1. Rising Prevalence of Gastrointestinal Disorders and Cancers

The global burden of gastrointestinal diseases, including colorectal cancer, gastric cancer, and benign strictures, continues to rise. This drives the demand for stents as a non-surgical solution to manage blockages and provide palliative care, especially in advanced cancer cases.

2. Technological Advancements in Stent Design

Modern stents now incorporate features such as anti-migration coatings, drug-eluting capabilities, and biodegradable materials. These innovations enhance patient safety, reduce the need for repeat procedures, and support market expansion.

3. Growing Preference for Minimally Invasive Treatments

Gastrointestinal stents offer a less invasive alternative to surgical interventions, minimizing hospitalization time, reducing complications, and aligning with the global trend towards less invasive medical procedures.

Restraints:

1. Risk of Complications and Stent Migration

Despite technological improvements, gastrointestinal stents can still pose risks such as perforation, stent migration, and bleeding. These complications may deter both physicians and patients from choosing stenting as a first-line treatment.

2. High Cost of Advanced Stents

Biodegradable and drug-eluting stents often come with higher price points, limiting their adoption in cost-sensitive and underdeveloped healthcare markets.

Opportunity:

1. Expanding Healthcare Infrastructure in Emerging Markets

Emerging economies, particularly in Asia-Pacific and Latin America, are increasing healthcare investments, leading to better diagnostic capabilities and access to advanced treatment options like gastrointestinal stents.

2. Increased Use of Biodegradable and Drug-Eluting Stents

The ongoing shift toward biodegradable and drug-eluting stents presents lucrative opportunities. These products promise fewer long-term complications and are gaining traction in both developed and emerging markets.

Market by System Type Insights:

Based on system type, the Biliary Stents segment dominated the market in 2023 due to the high incidence of bile duct obstruction, particularly among pancreatic and hepatobiliary cancer patients. However, the Duodenal Stents segment is expected to witness the fastest growth owing to increasing cases of gastric outlet obstruction and associated conditions.

Market by End-Use Insights:

The Hospitals segment held the largest share in 2023, driven by the availability of advanced diagnostic and interventional procedures and a high patient footfall. Ambulatory Surgical Centers (ASCs) are projected to grow at a significant pace, propelled by their cost-effectiveness and shorter recovery times, which align with patient preferences for outpatient care.

Market by Regional Insights:

North America led the global gastrointestinal stents market in 2023, owing to a strong healthcare infrastructure, widespread adoption of advanced stent technologies, and high prevalence of GI cancers. Asia-Pacific is projected to be the fastest-growing region during the forecast period, supported by rising healthcare expenditure, expanding medical tourism, and increasing cancer screening rates in countries like India, China, and South Korea.

Competitive Scenario:

Key players in the market include Boston Scientific Corporation, Cook Medical, Medtronic plc, Taewoong Medical Co., Ltd., Olympus Corporation, ELLA-CS, and Becton, Dickinson and Company (BD). These companies are focusing on expanding their product portfolios, gaining regulatory approvals, and entering strategic partnerships to solidify their global presence.

Scope of Work – Global Gastrointestinal Stents Market:

Report Metric Details

Market Size (2023) USD 513.2 million

Projected Market Size (2031) USD 872.9 million

CAGR (2023–2031) 6.8%

Market Segments By System Type (Esophageal, Biliary, Duodenal, Colonic)

By End-Use (Hospitals, ASCs, Specialty Clinics)

Growth Drivers Rising GI cancer incidence, technological advancements, preference for minimally invasive treatments

Opportunities Expansion in emerging markets, adoption of drug-eluting & biodegradable stents

Key Market Developments:

In 2023, Boston Scientific launched an advanced fully covered metal biliary stent with anti-migration technology, aiming to improve clinical outcomes in malignant obstructions.

In 2024, Cook Medical announced clinical trials for its next-generation biodegradable gastrointestinal stents in collaboration with leading oncology centers.

In 2025, Taewoong Medical expanded its footprint in Europe by acquiring a distribution network for its duodenal and esophageal stent line.

FAQs:

1) What is the current market size of the Global Gastrointestinal Stents Market?

The market was valued at USD 513.2 million in 2023.

2) What is the major growth driver of the Global Gastrointestinal Stents Market?

The major driver is the